R.W.W.); Vanderbilt University Healthcare Center, Nashville (J.A.S.); Netherlands Cancer Institute (J.B.H.) and VU University Medical Center (A.J.M.E.) — each in Amsterdam; University of Colorado Cancer Center, Aurora (R.G.); Institut Gustave Roussy, Villejuif, France (C.R.); University Hospital Essen, Essen (D.S., J.M.V.), German Cancer Investigation Center, University of Mannheim, Mannheim (J.C.H.), and Technical University Munich, Munich (C.P.) — all in Germany; Huntsman Cancer Institute, Salt Lake City (W.A.); Mount Sinai Complete Cancer Center, Miami (J.L.); Christie Hospital NHS Trust, Manchester (P.L.), and Southampton University Hospitals, Southampton (C.H.O.) — both inside the United kingdom; Washington University College of Medicine, St. Louis (G.P.L.); Princess Margaret Hospital, Toronto (D.H., I.Q.); Saint Louis Hospital, Paris (C.L.); Loyola University Medical Center, Maywood, IL (J.I.C.); Memorial Sloan-Kettering Cancer Center, New York (J.D.W.); H. Lee Moffitt Cancer Center, Tampa, FL (J.S.W.); Medarex, Bloomsbury, NJ (J.T., M.J.Y., G.M.N.); Bristol-Myers Squibb, Wallingford, CT (A.H.); along with the Earle A. Chiles Study Institute, Portland, OR (W.J.U.). In addition to the authors, the following investigators (listed by country in alphabetical order) participated in the study: Argentina: M. Chac , L. Koliren, G.L. Lerzo, R.L. Santos — all in Buenos Aires; Belgium: A. Awada (Brussels), V. Cocquyt (Ghent), J.Phycocyanobilin Inhibitor Kerger (Yvoir), J.Vorsetuzumab Purity & Documentation Thomas (Leuven), T.PMID:24428212 Velu (Brussels); Brazil: C. Barrios (Porto Alegre), C. Dzik (S Paulo), M. Federico (S Paulo), J. Hohmann (Barretos), M. Liberrati (Londrina), A.N Engl J Med. Author manuscript; obtainable in PMC 2013 January 19.Hodi et al.PageLima (Santo Andr, G. Schwartsmann (Porto Alegre), J. Segalla (Ja; Canada: T. Baetz (Kingston, ON), T. Cheng (Calgary, AB), W. Miller (Montreal), S. Rorke (St. John’s, NL), S. Verma (Ottawa), R. Wong (Winnipeg, MB); Chile: H. Harbst (Santiago), P. GonzalezMella (Vi del Mar), P. Salman (Santiago); France: F. Cambazard (Saint-Etienne), O. Dereure (Montpellier), B. Dreno (Nantes), L. Geoffrois (Vandoeuvre-l -Nancy), J-J. Grob (Marseille), T. Lesimple (Dunkerque), S. N rier (Lyon), N. Penel (Lille), A. Thyss (Good); Germany: J.C. Becker (W zburg), C. Garbe (T ingen), S. Grabbe (Molnz), U. Keilholz (Berlin), C. Loquai (Mainz), H. Naeher (Heidelberg), G. Shuler (Erlangen), U. Trefzer (Berlin), J. Welzel (Augsburg); Hungary: Z. Karolyi (Miskolc); Netherlands: R.L.H. Jansen (Maastricht); South Africa: G.L. Cohen (Pretoria), J.I. Raats (Panorama), D.A. Vorobiof (Morningside); Switzerland: R. Dummer (Zurich), O. Michielin (Lausanne); United kingdom: J. Barber (Cardiff), S. Danson (Sheffield), M. Gore (London), S. Houston (Surrey), C.G. Kelly (Newcastle-upon-Tyne), M. Middleton (Oxford), P.M. Patel (Nottingham), E. Rankin (Dundee, Scotland); United states: M. Adler (Vista, CA), T. Amatruda (Robbinsdale, MN), A. Amin (Charlotte, NC), C. Anderson (Columbia, MO), L. Blakely (Memphis, TN), E. Borden (Cleveland), S. Burdette-Radoux (Burlington, VT), R. Chapman (Detroit), J. Chesney (Louisville, KY), A. Cohn (Denver), F.A. Collichio (Chapel Hill, NC), G. Daniels (La Jolla, CA), J. Drabick (Hershey, PA), J.A. Figueroa (Lubbock, TX), J. Fleagle (Boulder, CO), J. Goydos (New Brunswick, NJ), N. Haas (Philadelphia), E. Hersh (Tucson, AZ), H.L. Kaufman (New York), K.D. Khan (Indianapolis), A. Khurshid (Arlington, TX), J.M. Kirkwood (Pittsburgh), J.J. Kirshner (East Syracuse, NY), H. Klu.